Use of zebrafish to study innate immunity to Shigella in vivo. (360G-Wellcome-097411_Z_11_B)

£229,000

Background: Several intracellular pathogens escape from phagosomes and reach the host cytosol where they can polymerize actin, leading to motility and cell-to-cell spread. However, only a small fraction of intracytosolic bacteria form actin tails, and a complete understanding of the molecular events restricting bacterial dissemination has not been obtained. Objectives: Using Shigella flexneri I will pursue the following aims: (1) To identify and characterize host and pathogen determinants un derlying the intracellular fate of cytosolic bacteria; (2) To investigate the role of discovered molecules and mechanisms in vivo using new experimental models of infection. Expected results: Completion of these objectives will provide insights into the mechanisms required for the control of infection by cytosolic host responses.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 229000
Applicant Surname Mostowy
Approval Committee Science Enhancement Committee
Award Date 2013-10-03T00:00:00+00:00
Financial Year 2013/14
Grant Programme: Title Enhancement
Internal ID 097411/Z/11/B
Lead Applicant Prof Serge Mostowy
Partnership Value 229000
Planned Dates: End Date 2017-03-31T00:00:00+00:00
Planned Dates: Start Date 2014-01-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London
Sponsor(s) Prof David Holden